Prof Jeanne Lubbe and Discovery Health weigh in. Discovery says GLP-1 claims tripled from 2022 to 2025, with members claiming for 5.4 months on average.
Recap by typeshit. Full story at thenational.co.za.
A guide to employer plans, Medicare Part D's weight-loss exclusion, Medicaid and paying cash, plus how added uses like sleep apnea open coverage.
Employers on the Andel marketplace set their own contribution toward Wegovy, the daily Wegovy pill and Wegovy HD, with manufacturer-direct pricing and no insurance involved.
Business Day says medicines endorsed by the WHO still aren't available to public sector patients. The drugs involved aren't named in the share.
A study of 288,907 insured people found other medical costs rose about 22 cents per drug dollar. Also covers Medicare's $245 Bridge price and employer cutbacks.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Loading…